The XYLASTRIN brand, founded in 2012 (Sweden), from 585 sister brands and 17478 competing brands. The XYLASTRIN brand is owned by ASTRAZENECA, a company listed in London. The International Securities Identification Number (ISIN) of ASTRAZENECA is GB0009895292. The sector of XYLASTRIN is Drug Manufacturers.